Xeris Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Adcock Ingram Holdings ZAR 4.89B 194.86M 2024-06
Celltrion KRW 5.37T 121.47B 2024-09
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Ecofibre AUD 37.37M 2.03M 2024-06
Eli Lilly USD 32.74B 1.32B 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Malin Corporation EUR 35.9M 100K 2024-06
Medical Developments International AUD 26.14M 4.89M 2024-06
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pharma Mar EUR 250.25M 12.23M 2024-12
Qiagen NV USD 1.96B 494.22M 2024-12
Sartorius EUR 1.97B 114.6M 2024-09
Sino Biopharmaceutical CNY 24.69B 536.67M 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Tilray USD 707.34M 18.54M 2024-11
Zz Pientze Pharmaceu 15.84B 718.65M 2024-09



Xeris Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.